Title |
Current and emerging treatment options for ANCA-associated vasculitis: potential role of belimumab and other BAFF/APRIL targeting agents
|
---|---|
Published in |
Drug Design, Development and Therapy, January 2015
|
DOI | 10.2147/dddt.s67264 |
Pubmed ID | |
Authors |
Aleksander Lenert, Petar Lenert |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 103 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 2 | 2% |
Netherlands | 1 | <1% |
Germany | 1 | <1% |
Italy | 1 | <1% |
Unknown | 98 | 95% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 21 | 20% |
Student > Bachelor | 15 | 15% |
Student > Ph. D. Student | 11 | 11% |
Student > Master | 11 | 11% |
Student > Doctoral Student | 7 | 7% |
Other | 18 | 17% |
Unknown | 20 | 19% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 45 | 44% |
Agricultural and Biological Sciences | 6 | 6% |
Biochemistry, Genetics and Molecular Biology | 5 | 5% |
Immunology and Microbiology | 4 | 4% |
Psychology | 4 | 4% |
Other | 15 | 15% |
Unknown | 24 | 23% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 April 2021.
All research outputs
#19,942,887
of 25,371,288 outputs
Outputs from Drug Design, Development and Therapy
#1,310
of 2,268 outputs
Outputs of similar age
#252,324
of 359,515 outputs
Outputs of similar age from Drug Design, Development and Therapy
#35
of 57 outputs
Altmetric has tracked 25,371,288 research outputs across all sources so far. This one is in the 18th percentile – i.e., 18% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,268 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.1. This one is in the 36th percentile – i.e., 36% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 359,515 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 25th percentile – i.e., 25% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 57 others from the same source and published within six weeks on either side of this one. This one is in the 36th percentile – i.e., 36% of its contemporaries scored the same or lower than it.